有机金属半三明治复合物,由8-基素衍生而成,具有增强可溶性的曼尼基:针对多药耐药癌症
Tamás Pivarcsik1,2, Szilárd Tóth3,4, Szonja P Pósa3
1MTA-SZTE Lendület Functional Metal Complexes Research Group, University of Szeged, Dóm tér 7-8, Szeged H-6720 , Hungary.
Inorganic chemistry
|December 5, 2024
概括
新型有机金属和复合体对抗多药耐药 (MDR) 癌细胞表现出强烈的活性. 最有前途的复合物,封装在纳米颗粒中,证明了对MDR癌症治疗的增强生物利用性和选择性.
科学领域:
- 无机化学 无机化学
- 药用化学 医学化学
- 纳米技术 纳米技术
背景情况:
- 药物耐药性是癌症治疗的一个重大挑战,限制了治疗疗效.
- 开发针对多药耐药 (MDR) 癌细胞的新型化合物至关重要.
研究的目的:
- 合成和表征新的有机金属和复合物,其中含有8-基林衍生的曼尼赫基 (HQCl-pyr,HQCl-pip).
- 评估这些复杂物在向和克服癌细胞中MDR的潜力.
- 为了提高生物可用性和药物输送使用类胺功能化纳米颗粒.
主要方法:
- 四种新型有机金属复合物的合成和表征: [Ru ((η6-p-cymene) ((HL) Cl]Cl和 [Rh ((η5-C5Me5) ((HL) Cl]Cl.
- 光谱分析 (NMR,质谱法,IR) 用于结构阐明和溶液特异化.
- 用X射线结晶学对关键复合物的详细结构分析.
- 在体外细胞毒性测定对MDR MES-SA/Dx5细胞系.
- 用于药物输送的氏体功能化纳米颗粒的制备和表征.
主要成果:
- 合成的复合物在溶液和生物矩阵中表现出高稳定性,与母联体相比,可溶性得到改善.
- 该Rh(η5-C5Me5) 复合体对具有高MDR选择性的MDR MES-SA/Dx5细胞 (IC50 = 0.19和0.22μM) 显示出强烈的细胞毒性.
- 化物功能化纳米颗粒显示了pH依赖的药物释放,在酸性pH下更快.
- 纳米粒子封装保留了载荷复合物的细胞毒性和选择性.
结论:
- HQCl-pip的有机金属Rh ((η5-C5Me5) 复合体是开发MDR选择性抗癌剂的非常有前途的候选者.
- 纳米颗粒配方增强了活性化合物的生物可用性和向性输送.
- 这种方法为克服癌症治疗中的耐药性提供了一个潜在的策略.
更多相关视频
11:14Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
57.5K
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
相关概念视频
01:46Electron Transport Chain: Complex I and II
11.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.5K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K